StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

STROBearishEarningsnews
Materiality pending

Analysts Estimate Sutro Biopharma, Inc. (STRO) to Report a Decline in Earnings: What to Look Out for

May 13, 2024, 11:09 AM EDT1 sourcesAI-analyzed

AI summary

What happened, with direct paths to the underlying reporting

- STRO expected to show decline in earnings and revenues for Q1 2024. - Analysts predict quarterly loss of $0.92/share and 8.7% revenue decrease. - Earnings ESP at -6.98%, making prediction difficult for STRO stock. - Recent history shows STRO beating EPS estimates three out of four quarters. Price Impact Rating: Bearish Impact Horizon Rating: Short-term Type: Research Analysis

  • STRO expected to show decline in earnings and revenues for Q1 2024.
  • Analysts predict quarterly loss of $0.92/share and 8.7% revenue decrease.
  • Earnings ESP at -6.98%, making prediction difficult for STRO stock.
  • Recent history shows STRO beating EPS estimates three out of four quarters.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.